_id
6919ef0b3c536f8df2318511
Ticker
TCF.LSE
Name
Theracryf Plc
Exchange
LSE
Address
Alderley Park, Nether Alderley, United Kingdom, SK10 4TG
Country
UK
Sector
Healthcare
Industry
Biotechnology
Currency
GBX
Website
https://theracryf.com
Description
Theracryf Plc, a clinical stage therapeutics company, engages in the development of therapeutics for oncology and behavioural brain disorders. The company develops orexin-1 antagonist for the treatment of binge eating disorder and anxiety; and atypical dopamine transporter inhibitor (DAT) to treat fatigue and narcolepsy. It also develops SFX-01 for the treatment of brain cancer glioblastoma and neurodevelopmental disorders. The company was formerly known as Evgen Pharma plc and changed its name to Theracryf Plc in April 2024. Theracryf Plc was incorporated in 2014 and is headquartered in Nether Alderley, the United Kingdom.
Last Close
2000
Volume
1008763
Current Price
0.2
Change
0
Last Updated
2025-12-30T11:37:18.774Z
Image
https://logo.clearbit.com/theracryf.com
Ipo Date
-
Market Cap
4297927
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
4
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
-
Cost Of Revenue
4000
Gross Profit
-4000
Operating Expenses
1367000
Operating Income
-1371000
Interest Expense
-
Pretax Income
-1313000
Net Income
-1313000
Eps
-0.0006119251279172855
Dividends Per Share
-
Shares Outstanding
2148963739
Income Tax Expense
-
EBITDA
-1309000
Operating Margin
-
Total Other Income Expense Net
58000
Cash
1455000
Short Term Investments
2041000
Receivables
666000
Inventories
-
Total Current Assets
4162000
Property Plant Equipment
-
Total Assets
6618000
Payables
-
Short Term Debt
-
Long Term Debt
-
Total Liabilities
1816000
Equity
4802000
Bs_currency_symbol
-
Depreciation
4000
Change In Working Capital
152000
Cash From Operations
-699000
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
44000
Net Change In Cash
-654000
Cf_currency_symbol
-
PE
-
PB
89.36640316534778
ROE
-27.342773844231573
ROA
-19.839830764581446
FCF
-699000
Fcf Percent
-
Piotroski FScore
1
Health Score
35
Deep Value Investing Score
4.5
Defensive Investing Score
5
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
2
Growth Investing Score
0.5
Momentum Investing Score
2.5
Net Net Investing Score
3
Quality Investing Score
3
Value Investing Score
3.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
-
Quarters > 0 > income Statement > cost Of Revenue
4000
Quarters > 0 > income Statement > gross Profit
-4000
Quarters > 0 > income Statement > operating Expenses
1367000
Quarters > 0 > income Statement > operating Income
-1371000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-1313000
Quarters > 0 > income Statement > net Income
-1313000
Quarters > 0 > income Statement > eps
-0.0006119251279172855
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
2145687340
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-1309000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
58000
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
1455000
Quarters > 0 > balance Sheet > short Term Investments
2041000
Quarters > 0 > balance Sheet > receivables
666000
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
4162000
Quarters > 0 > balance Sheet > property Plant Equipment
-
Quarters > 0 > balance Sheet > total Assets
6618000
Quarters > 0 > balance Sheet > payables
-
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
1816000
Quarters > 0 > balance Sheet > equity
4802000
Quarters > 0 > balance Sheet > currency_symbol
-
Quarters > 0 > cash Flow > net Income
-1313000
Quarters > 0 > cash Flow > depreciation
4000
Quarters > 0 > cash Flow > change In Working Capital
152000
Quarters > 0 > cash Flow > cash From Operations
-699000
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
44000
Quarters > 0 > cash Flow > net Change In Cash
-654000
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-0.0006119251279172855
Quarters > 0 > ratios > PB
89.36640316534778
Quarters > 0 > ratios > ROE
-27.342773844231573
Quarters > 0 > ratios > ROA
-19.839830764581446
Quarters > 0 > ratios > FCF
-699000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
35
Quarters > 1 > quarter
2025-03-31
Quarters > 1 > income Statement > revenue
-
Quarters > 1 > income Statement > cost Of Revenue
862000
Quarters > 1 > income Statement > gross Profit
-862000
Quarters > 1 > income Statement > operating Expenses
12000
Quarters > 1 > income Statement > operating Income
-874000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-840000
Quarters > 1 > income Statement > net Income
-696000
Quarters > 1 > income Statement > eps
-0.0010664907798631235
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
652607611
Quarters > 1 > income Statement > income Tax Expense
144000
Quarters > 1 > income Statement > EBITDA
-840000
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
34000
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
2109000
Quarters > 1 > balance Sheet > short Term Investments
2005000
Quarters > 1 > balance Sheet > receivables
404000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
5170000
Quarters > 1 > balance Sheet > property Plant Equipment
-
Quarters > 1 > balance Sheet > total Assets
7630000
Quarters > 1 > balance Sheet > payables
106000
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
1661000
Quarters > 1 > balance Sheet > equity
5969000
Quarters > 1 > balance Sheet > currency_symbol
GBP
Quarters > 1 > cash Flow > net Income
-696000
Quarters > 1 > cash Flow > depreciation
34000
Quarters > 1 > cash Flow > change In Working Capital
-126000
Quarters > 1 > cash Flow > cash From Operations
-970000
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-1992000
Quarters > 1 > cash Flow > cash From Financing
3886000
Quarters > 1 > cash Flow > net Change In Cash
913000
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
-0.0010664907798631235
Quarters > 1 > ratios > PB
21.86656428212431
Quarters > 1 > ratios > ROE
-11.660244597084938
Quarters > 1 > ratios > ROA
-9.121887287024903
Quarters > 1 > ratios > FCF
-970000
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
34
Quarters > 2 > quarter
2024-09-30
Quarters > 2 > income Statement > revenue
-
Quarters > 2 > income Statement > cost Of Revenue
35000
Quarters > 2 > income Statement > gross Profit
-35000
Quarters > 2 > income Statement > operating Expenses
1215000
Quarters > 2 > income Statement > operating Income
-1250000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-1245000
Quarters > 2 > income Statement > net Income
-1245000
Quarters > 2 > income Statement > eps
-0.004529115385515191
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
274888117
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-1210000
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
5000
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
1196000
Quarters > 2 > balance Sheet > short Term Investments
5000
Quarters > 2 > balance Sheet > receivables
837000
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
2038000
Quarters > 2 > balance Sheet > property Plant Equipment
0
Quarters > 2 > balance Sheet > total Assets
3135000
Quarters > 2 > balance Sheet > payables
467000
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
467000
Quarters > 2 > balance Sheet > equity
2668000
Quarters > 2 > balance Sheet > currency_symbol
GBP
Quarters > 2 > cash Flow > net Income
-1245000
Quarters > 2 > cash Flow > depreciation
35000
Quarters > 2 > cash Flow > change In Working Capital
-198000
Quarters > 2 > cash Flow > cash From Operations
-1392000
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-78000
Quarters > 2 > cash Flow > cash From Financing
661000
Quarters > 2 > cash Flow > net Change In Cash
-808000
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
-0.004529115385515191
Quarters > 2 > ratios > PB
20.606305622188906
Quarters > 2 > ratios > ROE
-46.664167916041976
Quarters > 2 > ratios > ROA
-39.71291866028708
Quarters > 2 > ratios > FCF
-1392000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
34
Quarters > 3 > quarter
2024-03-31
Quarters > 3 > income Statement > revenue
-
Quarters > 3 > income Statement > cost Of Revenue
5000
Quarters > 3 > income Statement > gross Profit
-5000
Quarters > 3 > income Statement > operating Expenses
2102000
Quarters > 3 > income Statement > operating Income
-2107000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-2107000
Quarters > 3 > income Statement > net Income
-1678000
Quarters > 3 > income Statement > eps
-0.00610430170031686
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
274888117
Quarters > 3 > income Statement > income Tax Expense
-429000
Quarters > 3 > income Statement > EBITDA
-2102000
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
-
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
2004000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
497000
Quarters > 3 > balance Sheet > inventories
-1000
Quarters > 3 > balance Sheet > total Current Assets
3027000
Quarters > 3 > balance Sheet > property Plant Equipment
1000
Quarters > 3 > balance Sheet > total Assets
3062000
Quarters > 3 > balance Sheet > payables
330000
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
721000
Quarters > 3 > balance Sheet > equity
2341000
Quarters > 3 > balance Sheet > currency_symbol
GBP
Quarters > 3 > cash Flow > net Income
-1678000
Quarters > 3 > cash Flow > depreciation
5000
Quarters > 3 > cash Flow > change In Working Capital
294000
Quarters > 3 > cash Flow > cash From Operations
-1724000
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
-
Quarters > 3 > cash Flow > net Change In Cash
-1724000
Quarters > 3 > cash Flow > currency_symbol
-
Quarters > 3 > ratios > PE
-0.00610430170031686
Quarters > 3 > ratios > PB
23.484674668944894
Quarters > 3 > ratios > ROE
-71.67876975651431
Quarters > 3 > ratios > ROA
-54.80078380143697
Quarters > 3 > ratios > FCF
-1724000
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
34
Annuals > 0 > quarter
2025-03-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
2112000
Annuals > 0 > income Statement > gross Profit
-2112000
Annuals > 0 > income Statement > operating Expenses
12000
Annuals > 0 > income Statement > operating Income
-2124000
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-2085000
Annuals > 0 > income Statement > net Income
-1941000
Annuals > 0 > income Statement > eps
-0.0036057220948267498
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
538311037
Annuals > 0 > income Statement > income Tax Expense
144000
Annuals > 0 > income Statement > EBITDA
-2055000
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
39000
Annuals > 0 > income Statement > currency_symbol
GBP
Annuals > 0 > balance Sheet > cash
2109000
Annuals > 0 > balance Sheet > short Term Investments
2005000
Annuals > 0 > balance Sheet > receivables
404000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
5170000
Annuals > 0 > balance Sheet > property Plant Equipment
-
Annuals > 0 > balance Sheet > total Assets
7630000
Annuals > 0 > balance Sheet > payables
106000
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
1661000
Annuals > 0 > balance Sheet > equity
5969000
Annuals > 0 > balance Sheet > currency_symbol
GBP
Annuals > 0 > cash Flow > net Income
-2085000
Annuals > 0 > cash Flow > depreciation
69000
Annuals > 0 > cash Flow > change In Working Capital
-493000
Annuals > 0 > cash Flow > cash From Operations
-2367000
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
-2075000
Annuals > 0 > cash Flow > cash From Financing
4547000
Annuals > 0 > cash Flow > net Change In Cash
105000
Annuals > 0 > cash Flow > currency_symbol
GBP
Annuals > 0 > ratios > PE
-0.0036057220948267498
Annuals > 0 > ratios > PB
16.458663805076228
Annuals > 0 > ratios > ROE
-32.5180097168705
Annuals > 0 > ratios > ROA
-25.439056356487548
Annuals > 0 > ratios > FCF
-2367000
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
27
Annuals > 1 > quarter
2024-03-31
Annuals > 1 > income Statement > revenue
396000
Annuals > 1 > income Statement > cost Of Revenue
11000
Annuals > 1 > income Statement > gross Profit
385000
Annuals > 1 > income Statement > operating Expenses
3945000
Annuals > 1 > income Statement > operating Income
-3560000
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-3566000
Annuals > 1 > income Statement > net Income
-3137000
Annuals > 1 > income Statement > eps
-0.011411915634025023
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
274888117
Annuals > 1 > income Statement > income Tax Expense
-429000
Annuals > 1 > income Statement > EBITDA
-3549000
Annuals > 1 > income Statement > operating Margin
-898.989898989899
Annuals > 1 > income Statement > total Other Income Expense Net
-6000
Annuals > 1 > income Statement > currency_symbol
GBP
Annuals > 1 > balance Sheet > cash
2004000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
497000
Annuals > 1 > balance Sheet > inventories
-1000
Annuals > 1 > balance Sheet > total Current Assets
3027000
Annuals > 1 > balance Sheet > property Plant Equipment
1000
Annuals > 1 > balance Sheet > total Assets
3062000
Annuals > 1 > balance Sheet > payables
330000
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
721000
Annuals > 1 > balance Sheet > equity
2341000
Annuals > 1 > balance Sheet > currency_symbol
GBP
Annuals > 1 > cash Flow > net Income
-3566000
Annuals > 1 > cash Flow > depreciation
11000
Annuals > 1 > cash Flow > change In Working Capital
-491000
Annuals > 1 > cash Flow > cash From Operations
-2996000
Annuals > 1 > cash Flow > capital Expenditures
0
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
-
Annuals > 1 > cash Flow > net Change In Cash
-2996000
Annuals > 1 > cash Flow > currency_symbol
GBP
Annuals > 1 > ratios > PE
-0.011411915634025023
Annuals > 1 > ratios > PB
21.429765635412213
Annuals > 1 > ratios > ROE
-134.00256300726184
Annuals > 1 > ratios > ROA
-102.44937949052905
Annuals > 1 > ratios > FCF
-2996000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-7.565656565656566
Annuals > 1 > health Score
26
Annuals > 2 > quarter
2023-03-31
Annuals > 2 > income Statement > revenue
442000
Annuals > 2 > income Statement > cost Of Revenue
13000
Annuals > 2 > income Statement > gross Profit
429000
Annuals > 2 > income Statement > operating Expenses
5499000
Annuals > 2 > income Statement > operating Income
-5070000
Annuals > 2 > income Statement > interest Expense
-
Annuals > 2 > income Statement > pretax Income
-5006000
Annuals > 2 > income Statement > net Income
-4043000
Annuals > 2 > income Statement > eps
-0.014707802010954152
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
274888117
Annuals > 2 > income Statement > income Tax Expense
-963000
Annuals > 2 > income Statement > EBITDA
-4993000
Annuals > 2 > income Statement > operating Margin
-1147.0588235294117
Annuals > 2 > income Statement > total Other Income Expense Net
98000
Annuals > 2 > income Statement > currency_symbol
GBP
Annuals > 2 > balance Sheet > cash
5000000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
1016000
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
6128000
Annuals > 2 > balance Sheet > property Plant Equipment
3000
Annuals > 2 > balance Sheet > total Assets
6174000
Annuals > 2 > balance Sheet > payables
402000
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
833000
Annuals > 2 > balance Sheet > equity
5341000
Annuals > 2 > balance Sheet > currency_symbol
GBP
Annuals > 2 > cash Flow > net Income
-4043000
Annuals > 2 > cash Flow > depreciation
13000
Annuals > 2 > cash Flow > change In Working Capital
332000
Annuals > 2 > cash Flow > cash From Operations
-4029000
Annuals > 2 > cash Flow > capital Expenditures
1000
Annuals > 2 > cash Flow > cash From Investing
4519000
Annuals > 2 > cash Flow > cash From Financing
-
Annuals > 2 > cash Flow > net Change In Cash
490000
Annuals > 2 > cash Flow > currency_symbol
GBP
Annuals > 2 > ratios > PE
-0.014707802010954152
Annuals > 2 > ratios > PB
9.392825566841417
Annuals > 2 > ratios > ROE
-75.69743493727766
Annuals > 2 > ratios > ROA
-65.48428895367671
Annuals > 2 > ratios > FCF
-4030000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-9.117647058823529
Annuals > 2 > health Score
26
Annuals > 3 > quarter
2022-03-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
16000
Annuals > 3 > income Statement > gross Profit
-16000
Annuals > 3 > income Statement > operating Expenses
3175000
Annuals > 3 > income Statement > operating Income
-3191000
Annuals > 3 > income Statement > interest Expense
-
Annuals > 3 > income Statement > pretax Income
-3169000
Annuals > 3 > income Statement > net Income
-2730000
Annuals > 3 > income Statement > eps
-0.009931313254985119
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
274888117
Annuals > 3 > income Statement > income Tax Expense
-439000
Annuals > 3 > income Statement > EBITDA
-3153000
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
22000
Annuals > 3 > income Statement > currency_symbol
GBP
Annuals > 3 > balance Sheet > cash
4510000
Annuals > 3 > balance Sheet > short Term Investments
4520000
Annuals > 3 > balance Sheet > receivables
483000
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
9580000
Annuals > 3 > balance Sheet > property Plant Equipment
5000
Annuals > 3 > balance Sheet > total Assets
9638000
Annuals > 3 > balance Sheet > payables
66000
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
411000
Annuals > 3 > balance Sheet > equity
9227000
Annuals > 3 > balance Sheet > currency_symbol
GBP
Annuals > 3 > cash Flow > net Income
-2730000
Annuals > 3 > cash Flow > depreciation
16000
Annuals > 3 > cash Flow > change In Working Capital
-86000
Annuals > 3 > cash Flow > cash From Operations
-2560000
Annuals > 3 > cash Flow > capital Expenditures
3000
Annuals > 3 > cash Flow > cash From Investing
1477000
Annuals > 3 > cash Flow > cash From Financing
-
Annuals > 3 > cash Flow > net Change In Cash
-1083000
Annuals > 3 > cash Flow > currency_symbol
GBP
Annuals > 3 > ratios > PE
-0.009931313254985119
Annuals > 3 > ratios > PB
5.436987249647773
Annuals > 3 > ratios > ROE
-29.587081391568226
Annuals > 3 > ratios > ROA
-28.325378709275782
Annuals > 3 > ratios > FCF
-2563000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
29
Valuation > metrics > PE
-0.0006119251279172855
Valuation > metrics > PB
89.36640316534778
Valuation > final Score
20
Valuation > verdict
2878.9% Overvalued
Profitability > metrics > ROE
-27.342773844231573
Profitability > metrics > ROA
-31.547333012974534
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.37817576009995835
Risk > metrics > Interest Coverage
-342.75
Risk > final Score
-1311
Risk > verdict
High
Liquidity > final Score
50
Liquidity > verdict
Weak
Prev Valuations > 0
20
Prev Valuations > 1
20
Prev Valuations > 2
20
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
15
Prev Risks > 0
80
Prev Risks > 1
-83
Prev Risks > 2
-1626
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T23:04:22.976Z
Earnings History > 0 > period
2026-03-31
Earnings History > 0 > report Date
2026-05-12
Earnings History > 0 > date
2026-03-31
Earnings History > 0 > before After Market
AfterMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-03-31
Earnings History > 1 > report Date
2025-06-02
Earnings History > 1 > date
2025-03-31
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
0
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2024-09-30
Earnings History > 2 > report Date
2024-11-28
Earnings History > 2 > date
2024-09-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
0
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2022-09-30
Earnings History > 3 > report Date
2022-12-05
Earnings History > 3 > date
2022-09-30
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.01
Earnings History > 3 > eps Estimate
0
Earnings History > 3 > eps Difference
-0.01
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2022-03-31
Earnings History > 4 > report Date
2022-06-08
Earnings History > 4 > date
2022-03-31
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
0
Earnings History > 4 > eps Estimate
0
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2021-09-30
Earnings History > 5 > report Date
2021-12-08
Earnings History > 5 > date
2021-09-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
-
Earnings History > 5 > eps Actual
-0.01
Earnings History > 5 > eps Estimate
0
Earnings History > 5 > eps Difference
-0.01
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2021-03-31
Earnings History > 6 > report Date
2021-06-14
Earnings History > 6 > date
2021-03-31
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
-
Earnings History > 6 > eps Actual
-0.01
Earnings History > 6 > eps Estimate
0
Earnings History > 6 > eps Difference
-0.01
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2020-09-30
Earnings History > 7 > report Date
2020-12-10
Earnings History > 7 > date
2020-09-30
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
-
Earnings History > 7 > eps Actual
-0.01
Earnings History > 7 > eps Estimate
0
Earnings History > 7 > eps Difference
-0.01
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2020-03-31
Earnings History > 8 > report Date
2020-06-16
Earnings History > 8 > date
2020-03-31
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
-
Earnings History > 8 > eps Actual
-0.01
Earnings History > 8 > eps Estimate
0
Earnings History > 8 > eps Difference
-0.01
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2019-09-30
Earnings History > 9 > report Date
2019-12-17
Earnings History > 9 > date
2019-09-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
-
Earnings History > 9 > eps Actual
-0.01
Earnings History > 9 > eps Estimate
0
Earnings History > 9 > eps Difference
-0.01
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2019-03-31
Earnings History > 10 > report Date
2019-06-13
Earnings History > 10 > date
2019-03-31
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
-
Earnings History > 10 > eps Actual
-0.01
Earnings History > 10 > eps Estimate
0
Earnings History > 10 > eps Difference
-0.01
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2018-09-30
Earnings History > 11 > report Date
2018-12-12
Earnings History > 11 > date
2018-09-30
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
-
Earnings History > 11 > eps Actual
-0.02
Earnings History > 11 > eps Estimate
0
Earnings History > 11 > eps Difference
-0.02
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2018-03-31
Earnings History > 12 > report Date
2018-06-21
Earnings History > 12 > date
2018-03-31
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
-
Earnings History > 12 > eps Actual
-0.01
Earnings History > 12 > eps Estimate
0
Earnings History > 12 > eps Difference
-0.01
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2017-09-30
Earnings History > 13 > report Date
2017-12-04
Earnings History > 13 > date
2017-09-30
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
-
Earnings History > 13 > eps Actual
-0.02
Earnings History > 13 > eps Estimate
0
Earnings History > 13 > eps Difference
-0.02
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2017-03-31
Earnings History > 14 > report Date
2017-05-29
Earnings History > 14 > date
2017-03-31
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
-
Earnings History > 14 > eps Actual
-0.02
Earnings History > 14 > eps Estimate
0
Earnings History > 14 > eps Difference
-0.02
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2016-09-30
Earnings History > 15 > report Date
2016-12-05
Earnings History > 15 > date
2016-09-30
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
-
Earnings History > 15 > eps Actual
-0.02
Earnings History > 15 > eps Estimate
0
Earnings History > 15 > eps Difference
-0.02
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2016-03-31
Earnings History > 16 > report Date
2016-05-31
Earnings History > 16 > date
2016-03-31
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
-
Earnings History > 16 > eps Actual
-0.03
Earnings History > 16 > eps Estimate
0
Earnings History > 16 > eps Difference
-0.03
Earnings History > 16 > surprise Percent
-
Theracryf Plc, a clinical stage therapeutics company, engages in the development of therapeutics for oncology and behavioural brain disorders. The company develops orexin-1 antagonist for the treatment of binge eating disorder and anxiety; and atypical dopamine transporter inhibitor (DAT) to treat fatigue and narcolepsy. It also develops SFX-01 for the treatment of brain cancer glioblastoma and neurodevelopmental disorders. The company was formerly known as Evgen Pharma plc and changed its name to Theracryf Plc in April 2024. Theracryf Plc was incorporated in 2014 and is headquartered in Nether Alderley, the United Kingdom.
Stock Price
GBp 0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2025-09-30)
Rating:
BUY
$
Analyst Picks
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Theracryf Plc
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2026-03-31
EPS Estimate
—
Date
2025-03-31
EPS Actual
0
EPS Estimate
0
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
£ 0
Cost Of Revenue
£ 0
Gross Profit
£ 0
Operating Expenses
£ 0
Operating Income
£ 0
Interest Expense
£ 0
Pretax Income
£ 0
Net Income
£ 0
Income Tax Expense
£ 0
EBITDA
£ 0
Total Other Income Expense Net
£ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
£ 0
Short Term Investments
£ 0
Receivables
£ 0
Inventories
£ 0
Total Current Assets
£ 0
Property Plant Equipment
£ 0
Total Assets
£ 0
Payables
£ 0
Short Term Debt
£ 0
Long Term Debt
£ 0
Total Liabilities
£ 0
Equity
£ 0
(Last Updated 2025-09-30)
Net Income
£ 0
Depreciation
£ 0
Change In Working Capital
£ 0
Cash From Operations
£ 0
Capital Expenditures
£ 0
Cash From Investing
£ 0
Cash From Financing
£ 0
Net Change In Cash
£ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.